Biopharma Bucking Market Trends on Positive FDA Feedback
October 31 2024 - 1:00PM
AllPennyStocks.com
This firm’s treatment for a disfiguring skin infection has
demonstrated safety and efficacy across multiple Phase 2 and Phase
3 studies, and shares are holding their own despite
today's...
To read the full story on AllPennyStocks.com, click
here.
Appili Therapeutics (PK) (USOTC:APLIF)
Historical Stock Chart
From Oct 2024 to Nov 2024
Appili Therapeutics (PK) (USOTC:APLIF)
Historical Stock Chart
From Nov 2023 to Nov 2024